Gene Name GenBank accession no. fg (I/N) fg(U/N) fg(I/U) P-value (I:N) P-value (U:N) P-value(I:U) Unigene no. GO no. Chromosomal location dermal/stromal? KIAA0633 protein (KIAA0633) AB014533 0.5 0.8 0.5 7.36E-06 4.20E-02 1.64E-07 Hs.33010 N/A 7p12.1 cytidine monophosphate-N-acetylneuraminic acid hydroxylase (CMP-N-acetylneuraminate monooxygenase) (CMAH) D86324 0.3 0.8 0.4 5.40E-05 1.05E-01 1.63E-07 Hs.24697 N/A 6p22-p23 ESTs () AI798199 0.5 2.1 0.3 2.05E-01 3.45E-02 2.37E-03 Hs.344902 N/A ESTs () H65393 0.3 1.3 0.3 1.92E-03 7.69E-02 1.26E-04 Hs.248822 N/A metallothionein 1L (MT1L) AA224832 0.4 0.7 0.6 6.18E-04 3.46E-02 1.34E-05 Hs.94360 GO:0005505 heavy metal binding 16q13 AI688299 0.4 0.9 0.5 4.85E-04 2.71E-01 1.13E-05 GO:0005624 membrane fraction keratin 15 (KRT15) X07696 0.4 0.8 0.5 1.54E-04 6.84E-02 9.21E-05 Hs.80342 GO:0005882 intermediate filament 17q21 "Homo sapiens, clone IMAGE:3447394, mRNA, partial cds ()" W31096 0.2 1 0.2 2.80E-07 9.12E-01 1.71E-06 Hs.237617 N/A M76665 0.4 0.9 0.4 1.54E-05 5.88E-01 6.55E-06 N/A 1q32-q41 "interleukin 1, zeta (FIL1(ZETA))" AI343258 0.3 1.1 0.2 2.03E-04 6.74E-01 9.69E-06 Hs.166371 N/A 2q12-q14.1 low density lipoprotein receptor-related protein 4 (LRP4) AB011540 0.5 0.9 0.5 1.93E-05 1.32E-01 3.30E-05 Hs.4930 N/A 11p11.2-p12 claudin 1 (CLDN1) AI452474 0.4 1.1 0.4 4.50E-05 2.88E-01 3.22E-07 Hs.7327 GO:0005624 membrane fraction 3q28-q29 brother of CDO (BOC) AA126704 0 1 0 1.53E-08 8.04E-01 1.29E-07 Hs.339352 N/A 3q13.2 Homo sapiens clone IMAGE 21721 () AI761647 0.4 0.8 0.4 2.34E-04 1.34E-01 1.04E-04 Hs.146007 N/A apolipoprotein C-I (APOC1) AA976838 0.4 1 0.5 9.94E-04 8.39E-01 8.14E-06 Hs.268571 N/A 19q13.2 claudin 8 (CLDN8) AL049977 0.4 0.7 0.5 8.95E-05 1.24E-02 6.61E-06 Hs.162209 N/A 21q22.11 "inhibitor of DNA binding 4, dominant negative helix-loop-helix protein (ID4)" AL022726 0.2 0.8 0.3 5.31E-05 6.27E-02 6.74E-09 Hs.34853 GO:0005634 nucleus 6p22-p21 DKFZP586N2124 protein (DKFZP586N2124) AI739159 0.3 0.9 0.3 2.61E-06 3.08E-01 6.84E-04 Hs.61898 N/A 11q14 apolipoprotein E (APOE) M12529 0.3 0.9 0.3 1.93E-04 3.90E-01 1.18E-07 Hs.169401 N/A 19q13.2 kynureninase (L-kynurenine hydrolase) (KYNU) D55639 0.2 1 0.1 3.21E-01 6.80E-01 2.88E-01 Hs.169139 N/A 2q22.1 thyroid hormone receptor interactor 10 (TRIP10) AJ000414 0.4 1 0.4 1.06E-06 6.79E-01 7.09E-06 Hs.73999 N/A 19p13.3 peroxisomal farnesylated protein (PXF) Y09048 0.5 1 0.5 1.18E-03 7.07E-01 1.34E-05 Hs.168670 GO:0005777 peroxisome 1q22 hypothetical protein DKFZp434A1319 (DKFZP434A1319) AI628039 -0.3 1 -0.3 1.63E-07 9.44E-01 1.51E-07 Hs.307084 N/A 16q22.1 ESTs () AI186548 0 0.9 0 8.32E-05 6.45E-01 1.23E-06 Hs.61297 N/A hypothetical protein MGC2650 (MGC2650) AI885381 0.5 0.9 0.6 4.69E-05 2.68E-01 1.71E-06 Hs.61273 N/A 19q13.32 ESTs () W01370 0.2 1.4 0.2 9.59E-04 3.79E-02 5.88E-08 Hs.46824 N/A KIAA0456 protein (SRGAP2) AB007925 0.4 0.9 0.5 2.91E-04 4.33E-01 5.10E-08 Hs.5003 GO:0005096 GTPase activator 1q25.2 ESTs () AI632006 0.4 0.9 0.4 7.18E-04 6.73E-01 2.73E-04 Hs.293451 N/A cysteine-rich protein 1 (intestinal) (CRIP1) AI017574 0.4 1 0.4 1.73E-04 7.15E-01 1.19E-07 Hs.17409 N/A 7q11.23 Wnt inhibitory factor-1 (WIF-1) W27944 0.1 0.7 0.1 1.23E-04 1.35E-01 3.37E-04 Hs.284122 N/A 12q14.2 cystatin E/M (CST6) W68521 0.3 0.9 0.4 6.11E-06 4.31E-01 6.88E-08 Hs.83393 GO:0004870 thiol protease inhibitor 11q13 "coagulation factor III (thromboplastin, tissue factor) (F3)" J02931 0.2 0.8 0.2 4.24E-04 1.42E-01 3.77E-08 Hs.62192 N/A 1p22-p21 "small inducible cytokine subfamily A (Cys-Cys), member 27 (SCYA27)" AJ243542 0.2 0.8 0.3 9.12E-05 2.84E-01 2.73E-06 Hs.225948 GO:0005125 cytokine 9p13 KIAA0450 gene product (KIAA0450) AB007919 0.4 0.8 0.5 1.15E-04 3.76E-02 1.59E-07 Hs.170156 N/A 1p36.32 GATA-binding protein 3 (GATA3) X58072 0.3 0.7 0.4 1.89E-04 3.37E-02 1.35E-07 Hs.169946 GO:0005634 nucleus 10p15 cathepsin L2 (CTSL2) AB001928 0.3 0.9 0.4 3.23E-03 6.70E-01 1.26E-05 Hs.87417 3.4.22.15 GO:0005764 lysosome 9q22.2 hepatocellular carcinoma antigen gene 520 (LOC63928) AA527435 0.4 1.1 0.3 1.04E-03 6.42E-01 1.68E-06 Hs.178589 GO:0005509 calcium binding 16p12.3 ESTs () AA913840 0.4 0.8 0.5 1.09E-06 4.42E-02 1.48E-06 Hs.98903 N/A "proteolipid protein 1 (Pelizaeus-Merzbacher disease, spastic paraplegia 2, uncomplicated) (PLP1)" M54927 0.6 1 0.5 1.48E-03 6.83E-01 1.36E-06 Hs.1787 N/A Xq22 ESTs () AI279137 0.3 0.9 0.3 1.36E-07 1.01E-01 6.58E-06 Hs.151498 N/A "kallikrein 1, renal/pancreas/salivary (KLK1)" M25629 0.3 0.8 0.4 7.69E-04 1.78E-01 7.90E-07 Hs.123107 N/A 19q13.3 "Homo sapiens mRNA for FLJ00067 protein, partial cds ()" AA621650 -0.7 1.1 -0.6 1.41E-08 2.76E-01 4.21E-07 Hs.41045 N/A Homo sapiens clone 23664 and 23905 mRNA sequence () AF035315 0.5 1.1 0.4 4.62E-09 5.04E-01 7.42E-06 Hs.180737 N/A ESTs () AI493128 0.1 1.2 0.1 2.57E-05 1.37E-01 5.72E-06 Hs.231850 N/A "microseminoprotein, beta- (MSMB)" AA532495 0.1 1.2 0.1 2.36E-02 5.15E-01 4.10E-06 Hs.183752 N/A 10q11.2 "aldehyde dehydrogenase 3 family, member A2 (ALDH3A2)" U46689 0.4 0.9 0.5 8.02E-05 5.53E-01 1.14E-05 Hs.159608 1.2.1.3 GO:0005624 membrane fraction 17p11.2 "ESTs, Moderately similar to AOHUBA beta-N-acetylhexosaminidase [H.sapiens] ()" AI674880 0.3 1.7 0.2 1.05E-02 1.88E-02 8.23E-08 Hs.340721 3.2.1.52 GO:0005764 lysosome prostate stem cell antigen (PSCA) AI583077 0.5 1.1 0.4 5.38E-07 1.90E-02 5.04E-08 Hs.20166 GO:0006620 post-translational membrane targeting 8q24.2 ESTs () W35214 0.2 1.2 0.2 1.39E-03 3.84E-01 5.90E-05 Hs.173059 N/A "catenin, beta-interacting protein 1 (CTNNBIP1)" W21787 0.4 0.9 0.5 9.99E-04 2.83E-01 3.59E-07 Hs.99816 N/A 1p36.22 chromosome 21 open reading frame 25 (C21orf25) AL050173 0.5 1 0.5 6.86E-05 9.33E-01 4.38E-07 Hs.16007 N/A 21q22.3 "protein phosphatase 2 (formerly 2A), regulatory subunit A (PR 65), beta isoform (PPP2R1B)" R76636 0.2 0.8 0.3 4.72E-04 2.24E-01 8.70E-04 Hs.108705 N/A 11q23